Results 141 to 150 of about 178,362 (241)

Radical model of arsenic(III) toxicity: Theoretical and EPR spin trapping studies [PDF]

, 2014
Antal Rockenbauer, Aposhian H. V., Aposhian H. V., Argos M., Bailey K. A., Barone V., Barone V., Bauza A., Becke A. D., Becke A. D., Burrows G. J., Buxton G. V., Chen Y. C., Cossi M., Cullen W. R., Cullen W. R., Dimaio A. J., Egorochkin A. N., Fei H., Frederick A. Villamena, Frisch M. J., He S.-G., Hehre W. J., Hernandez A., Howard J. A., Hug S. J., Hughes M. F., Kao W. H., Klaening U. K., Kojima C., Kumazaki M., Labanowski J. W., Lee C., Lee H., Leyssens T., Liu S. X., Mandal B. K., Mass M. J., Morales K. H., Muniz Ortiz J. G., Naranmandura H., Nesnow S., Parr R. G., Pedro L. Zamora, Petrick J. S., Petrick J. S., Ramanathan K., Rassolov V. A., Reed A. E., Rockenbauer A., Scott A. P., Scott N., Shen Z. X., Shi H., Soignet S. L., States J. C., Tarroni R., Thomas D. J., Tomasi J., Tomasi J., Vahidnia A., Vahter M., Wang T. S., Xie R., Yamanaka K., Zakharyan R. A., Zelenik Pevec A., Zhang W.   +67 more
core   +1 more source

Acute arsenic trioxide inhibits the cardiac transient outward K⁺ current (I_to) and human K_v4.3/KChIP2c channels. [PDF]

Curr Res Struct Biol
Mancilla Simbro C, Islas ÁA, Herrera Salcedo FD, Pérez Cortes E, Ramírez Mata A, Sanchéz González J, Reyes Carmona S, Villa Diaz F, Ríos Cano S, Moreno L, Ruíz Castelan J, López Martínez EL, Scior T, Olea-Amezcua MA, León Magdaleno JS, Villanueva Castillo A, Baez Castillo E.   +16 more
europepmc   +1 more source

Investigating the Mechanisms of Combined Therapy for MCF-7 Breast Cancer Cells Using Arsenic Trioxide and Resveratrol through Network Pharmacology. [PDF]

Phenomics
Hu H, Wu Y, Hong J, Wang H, Zhang X, Huang G, Zhu X.   +6 more
europepmc   +1 more source

Arsenic trioxide-induced acute kidney injury: OPA1- and Drp1-mediated mitochondrial dynamics imbalance, PINK1/Parkin-dependent mitophagy, and Chuanhuang Fang III. [PDF]

Front Mol Biosci
Wang P, Wu Z, Song Z, Deng X, Zhang Y, Gong X.   +5 more
europepmc   +1 more source

Arsenic trioxide for reprogramming the bone marrow microenvironment to eliminate acute myeloid leukemia blasts. [PDF]

Hemasphere
Kegyes D, Teodorescu P, Supeanu T, Nagai Y, Zhong G, Mathews V, Isoherranen N, Ghiaur G.   +7 more
europepmc   +1 more source

Arsenic trioxide regulates DYNAP through hsa-mir-573 and inhibits the proliferation of laryngeal cancer. [PDF]

Sci Rep
Ren Y, Yang X, Hui Y, Chen W, Cheng Y, Zhang N, Liu T, Yang X, Li X.   +8 more
europepmc   +1 more source

[Expression of Concern] S100A8‑targeting siRNA enhances arsenic trioxide‑induced myeloid leukemia cell death by down‑regulating autophagy. [PDF]

Int J Mol Med
Yang L, Yang M, Zhang H, Wang Z, Yu Y, Xie M, Zhao M, Liu L, Cao L.   +8 more
europepmc   +1 more source

Melphalan improves toxicity of arsenic trioxide in adult T-cell leukemia/lymphoma cells. [PDF]

Biochem Biophys Rep
Khodadadi F, Sadeghian MH, Delbari Z, Kazemi M, Koohpaykar H, Rassouli FB.   +5 more
europepmc   +1 more source

Silencing NRF2 enhances arsenic trioxide-induced ferroptosis in hepatocellular carcinoma cells. [PDF]

PLoS One
Huang M, Li D, Xia Z, Liao S, Si W, Yuan C, Liao Y, Wu W, Jiang M, Yu X, Quan Y.   +10 more
europepmc   +1 more source

Influence of white blood cell count trajectories on the risk of differentiation syndrome during induction therapy with all-trans-retinoic acid and arsenic trioxide in pediatric acute promyelocytic leukemia. [PDF]

Front Pediatr
Fu H, Liu Y, Hu S.
europepmc   +1 more source